Clinical use of etodolac for the treatment of lumbar disc herniation

Current Medical Research and Opinion

Volumn 15, Issue 3, 1999, Pages 193-201

  Hatori, Masahito ^a   Kokubun, Shoichi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adverse drug reactions; Cyclo oxygenase 2 (COX 2) inhibitors; Efficacy; Etodolac; Lumbar disc herniation; NSAIDs; Prostaglandins

Indexed keywords

ETODOLAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER FUNCTION; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GAIT; HUMAN; LEG PAIN; LOW BACK PAIN; LUMBAR DISK HERNIA; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; SENSORY DYSFUNCTION; STOMACH PAIN;

EID: 0032820233     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007999909114091     Document Type: Article

References (27)

1. Armstrong, C. P. and Blower, A. L. (1987). Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut, 28, 527-532.
2. Berry, H., Bloom, B., Hamilton, E. B. D. and Swinson, D. R. (1982). Naproxen sodium, diflunisal, and placebo in the treatment of chronic back pain. Ann. Rheum. Dis., 41, 129-132.
3. Bijlsma, A. (1978). The long-term efficacy and tolerability of voltaren (diclofenac sodium) and indomethacin in rheumatoid arthritis. Scand. J. Rheumatol., Suppl 22, 74-80.
4. Deyo, R. A. (1983). Conservative therapy for low back pain. Distinguishing useful from useless therapy. JAMA, 250, 1057-1062.
5. Fries, J. F., Miller, S. R., Spitz, P. W., Williams, C. A., Hubert, H. B. and Bloch, D. A. (1989). Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterol., 96, 647-655.
6. Goldie, I. (1968). A clinical trial with indomethacin (indomee) in low back pain and sciatica. Acta. Orthop. Scand., 39, 117-128.
7. Graham, D. Y. and Smith, J. L. (1988). Gastroduodenal complications of chronic NSAID therapy. Am. J. Gastroenterol., 83, 1081-1084.
8. Griffin, M. R., Ray, W. A. and Schaffner, W. (1988). Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann. Intern. Med., 109, 359-363.
9. Hatori, M., Sakurai, M., Kokubun, S. and Rijal, K. P. (1990). Piroxicam suppositories in the treatment of osteoarthritis of the knee joint. Clin. Ther., 12, 227-229.
10. Hatori, M., Sakurai, M. and Miyasaka, Y. (1992). Clinical evaluation of BPAA patch in the treatment of extremity trauma. Contemp. Orthop., 24, 721-727.
11. Hatori, M. and Kokubun, S. (1997). Clinical evaluation of indomethacin-containing patches for osteoarthritis and extremity trauma. Curr. Med. Res. Opin., 13, 511-515.
12. Hatori, M. and Kokubun, S. (1998). The long-term efficacy and tolerability of the new anti-inflammatory agent zaltoprofen in rheumatoid arthritis. Curr. Med. Res. Opin., 14, 79-87.
13. Inoue, K., Fujisawa, H., Motonaga, A., Inoue, Y., Kyoi, T., Ueda, F. and Kimura, K. (1994). Anti-inflammatory effects of etodolac: comparison with other nonsteroidal anti-inflammatory drugs. Biol. Pharm. Bull., 17, 1577-1583.
14. Izumida, S. and Inoue, S. (1986). Assessment of treatment for low back pain, Japanese Orthopaedic Association. J. Jpn. Orthop. Assoc., 60, 391-394.
15. Jallad, N. S., Sanda, M., Salom, I. L., Perdomo C. S., Garg, D. C., Mullane, J. F. and Weidler, D. J. (1986). Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam. Am. J. Med. Sci., 292, 272-276.
16. Kawai, S., Nishida, S., Kato, M., Furumaya, Y., Okamoto, R., Koshino, T. and Mizushima, Y. (1998). Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. Eur. J. Pharmacol., 347, 87-94.
17. Lanza, F., Rack, M. F., Lynn, M., Wolf, J. and Sanda, M. (1987). An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa. J. Rheumatol., 14, 338-341.
18. Lockie, L. M. (1986). Tolerability and efficacy of long-term daily administration of indomethacin for moderate to severe chronic arthritic disorders. Clin. Ther., 8, 398-405.
19. Macnab, I. (1977). Conservative treatment. Backache, Williams & Wilkins, Baltimore, pp. 181-184.
20. Martel, R. R. and Klicius, J. (1982). Comparison in rats of the anti-inflammatory and gastric irritant effects of etodolac with several clinically effective anti-inflammatory drugs. Agents Actions, 12, 295-297.
21. Ono, K., Komatsubara, Y., Akahori, O., Mizushima, T., Doi, T., Kamei, M., Yamamoto, T. and Ohzono, K. (1991). Clinical evaluation of RAK-591 (etodolac) on low back pain, cervicobrachial syndrome and frozen shoulder - double blind study in comparison with diclofenac sodium. J. Clin. Ther. Med., 7, 799-834.
22. Rodnan, G. P., Schumacher, H. R. and Zvaifler, N. J. (1983). Intervertebral Disc Disease. Primers on Rheumatic Diseases, The Arthritis Foundation, Atlanta, Georgia, 8th edn, pp. 149-151.
23. Saal, J. A. and Saal, J. S. (1989). Nonoperative treatment of herniated lumbar intervertebral disc with radiculopathy. An outcome study. Spine, 14, 431-437.
24. Salom, I. L., Jacob, G., Jallad, N., Perdomo, C. A., Mullane, J. F. and Weidler, D. (1984). Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males. J. Clin. Pharmacol., 24, 140-246.
25. Swift, G. L., Arnold, J., Williams, G. T., Williams, B. D., Rhodes, J. and Khan, F. (1992). Risk of ulceration with long-term indomethacin: endoscopic and histological changes in upper gastro-intestinal mucosa. Digestion, 53, 88-93.
26. Tokuhiro, A., Mugikura, S., Miyatsu, M., Kamo, Y., Yasuda, M., Onodera, N., Miyake, Y., Mikami, K., Sato, Y., Funakoshi M., Yagura, Y. and Matsuno, T. (1999). Longterm clinical evaluation of Hypen on osteoarthritis of the knee. J. Clin. Ther. Med., 15, 113-126.
27. Wijnands, M., van Riel, P., van't Hof, M., Gribnau, F. and van de Putte, L. (1991). Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis. A prospective drug survival study. J. Rheumatol., 18, 184-187.